Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2025 Rank: 36,735
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 705 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36,735 | 38,277 |
| Total Cites | 1,467 | 1,642 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 47 | 47 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 77 | 77 |
| Total Cites to Single+First Authored Papers | 64 | 69 |
| Number of Single+First+Last Authored Papers | 193 | 193 |
| Total Cites to Single+First+Last Authored Papers | 207 | 218 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,148 | 1,233 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
10.66%
|
|
Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2024 Rank: 33,953
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 712 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33,953 | 36,621 |
| Total Cites | 1,460 | 1,626 |
| H-index | 18 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 47 | 47 |
| Total Cites to Single Authored Papers | 32 | 32 |
| Number of Single+First Authored Papers | 77 | 77 |
| Total Cites to Single+First Authored Papers | 72 | 75 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 225 | 231 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,157 | 1,241 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.31 |
| Self-Citation Percentage |
10.21%
|
|
Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2023 Rank: 32,329
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 747 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,329 | 30,266 |
| Total Cites | 1,611 | 1,845 |
| H-index | 19 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 47 | 47 |
| Total Cites to Single Authored Papers | 31 | 32 |
| Number of Single+First Authored Papers | 77 | 77 |
| Total Cites to Single+First Authored Papers | 84 | 86 |
| Number of Single+First+Last Authored Papers | 189 | 189 |
| Total Cites to Single+First+Last Authored Papers | 292 | 304 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,241 | 1,340 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.38 |
| Self-Citation Percentage |
12.68%
|
|
Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2022 Rank: 27,482
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 751 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27,482 | 24,654 |
| Total Cites | 1,760 | 1,966 |
| H-index | 21 | 22 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 45 | 45 |
| Total Cites to Single Authored Papers | 24 | 28 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 86 | 96 |
| Number of Single+First+Last Authored Papers | 176 | 176 |
| Total Cites to Single+First+Last Authored Papers | 267 | 290 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,305 | 1,404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.40 |
| Self-Citation Percentage |
10.48%
|
|
Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2021 Rank: 19,628
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 495 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19,628 | 19,630 |
| Total Cites | 2,696 | 3,037 |
| H-index | 26 | 28 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 53 | 54 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 148 | 152 |
| Number of Single+First+Last Authored Papers | 179 | 179 |
| Total Cites to Single+First+Last Authored Papers | 478 | 500 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,038 | 2,211 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
11.23%
|
|
Rowe, Jacob M.
Shaare Zedek Medical Center,
Israel
2020 Rank: 19,290
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 448 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19,290 | 18,981 |
| Total Cites | 1,960 | 2,241 |
| H-index | 22 | 25 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 36 | 37 |
| Number of Single+First Authored Papers | 66 | 66 |
| Total Cites to Single+First Authored Papers | 128 | 131 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 387 | 406 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,509 | 1,646 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.36 |
| Self-Citation Percentage |
12.54%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.